Skip to main content
SpringerLink
Log in

Die diabetische Neuropathie

Diabetic neuropathy

  • leitlinien für die praxis
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Der Begriff der diabetischen Neuropathie umfasst Mono- und Polyneuropathieformen, die diabetische Radikulopathie und die autonome Neuropathie. Die Leitlinienempfehlungen beschreiben die klinischen Symptome und diagnostischen Möglichkeiten, sowie die Therapiemaßnahmen insbesondere bei der schmerzhaften Form der sensomotorischen Neuropathie.

Summary

These are the guidelines for diagnosis and treatment of diabetic neuropathy. This diabetic late complication comprises a number of mono- and polyneuropathies, plexopathies, radiculopathies and autonomic neuropathy. The position statement summarizes characteristic clinical symptoms and techniques for diagnostic assessment of diabetic neuropathy. Recommendations for the therapeutic management of diabetic neuropathy, especially for the control of pain in sensomotoric neuropathy, are provided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. American Diabetes Association. Standards of medical care in diabetes – 2012. Diabetes Care. 2012;35(Suppl 1):S11–63.

    Google Scholar 

  2. Ziegler D, Gries FA. Epidemiologie der peripheren diabetischen Neuropathie. Diabetes Stoffwechs. 1992;1:24–8.

    Google Scholar 

  3. Callaghan BC, Cheng HAT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatment. Lancet Neurol. 2012;11:521–34.

    Article  PubMed  Google Scholar 

  4. Young MJ, Boulton AJM, MacIEOD, et al. A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital population. Diabetologia 1993;36:150–4.

  5. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck. KORA Study Group: neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Survey S2 and S3. Pain Med. 2009;10:393–400.

    Google Scholar 

  6. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boultin AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34:2220–4.

    Article  PubMed  Google Scholar 

  7. Dyck PJ, Karnes JL, O’Brien PC, et al. The Rochester diabetic neuropathy study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 1992;42:1164–70.

    Article  PubMed  CAS  Google Scholar 

  8. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology 1993;43:817–24.

    Article  PubMed  CAS  Google Scholar 

  9. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complication study. Diabetes 1989;38:1456–61.

    Article  PubMed  CAS  Google Scholar 

  10. Van de Pollyranse LV, Valk GD, Renders CM, Heine RJ, Eijk JTM. Longitudinal assessment of the development of diabetic polyneuropathies and associated risk factors. Diabetic Med. 2003;19:771–9.

    Article  Google Scholar 

  11. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14.

    Article  PubMed  Google Scholar 

  12. Sima AA, Sugimoto K. Experimental diabetic neuropathy. An update. Diabetologia 1999;42:773–88.

    Article  PubMed  CAS  Google Scholar 

  13. Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanism as therapeutic targets. Nat Rev Neurol. 2011;7:573–83.

    Article  PubMed  CAS  Google Scholar 

  14. Yagihashi S, Yamagishi SI, Wada RI, et al. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 2001;124:2448–58.

    Article  PubMed  CAS  Google Scholar 

  15. Hoeldike RD, Bryner KD, Van Dyke K. Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res. 2011;21:19–28.

    Article  Google Scholar 

  16. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab. 2009;94:2157–63.

    Article  PubMed  CAS  Google Scholar 

  17. Ziegler D. Diagnosis and treatment of diabetic autonomic neuropathy. Curr Diab Rep. 2011;3:216–27.

    Google Scholar 

  18. Vinik AI, Maser RE, Mitchell BD, Freema R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.

    Article  PubMed  Google Scholar 

  19. Tesfaye S, Vileikyte L, Rayman G, et al. On behalf of The Toronto Expert Panel on Diabetic Neuropathy. Diabetes Metab Res Rev. 2011;27:629–38.

    Article  Google Scholar 

  20. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther. 1996;76:68–71.

    PubMed  CAS  Google Scholar 

  21. Meijer JW, Bosma E, Leprandt JD, Links TP, Smit AJ, Stewart RE, Van Der Hoeven JH, Hoogenberg K. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptoms and diabetic neuropathy examination score. Diabetes Care. 2003;26:697–701.

    Article  PubMed  Google Scholar 

  22. Rahman M, Griffin SJ, Rathman W, Wareham NJ. How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-bases comparison of four measures. Diabet Med. 2003;20:368–374.

    Article  PubMed  CAS  Google Scholar 

  23. Feldman EL. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–9.

    Article  PubMed  CAS  Google Scholar 

  24. Bril V, England JD, Franklin GM, Backonja M, Cohen JA, Del Toro DR, Feldman EL, Iverson DJ, Perkins B, Russell JW, Zochodne DW. Evidence-based guideline: treatment of painful diabetic neuropathy – report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine& Rehabilitation. Muscle Nerve. 2011;43:910–17.

    Article  PubMed  Google Scholar 

  25. Diabetes Control and Complication Trial Research Group. The effects of intensive treatment of diabetes on the development and progressive of long term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  26. Martin CL, Albers J, Herman WH, et al. Neuropathy among the Diabetes Control and Complications Trial Cohort 8 years after trial. Diabetes Care. 2006;29:340–4.

    Article  PubMed  Google Scholar 

  27. Gremizzi C, Vergani A, Paloschi V, Secchi A. Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant. 2010;15:119–23.

    Article  PubMed  Google Scholar 

  28. UK Prospective Diabetes (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and rate of complication in patients with type 2 diabetes (UKPDS 33). Lancet 1998;12:837–63.

    Google Scholar 

  29. Holman RR, Paul SK, Bethal MA, et al. 10-years follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–84.

    Article  PubMed  CAS  Google Scholar 

  30. Amthor KF, Dahl-Jorgensen K, Berg TJ, et al. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients. The Oslo study. Diabetologia 1994;37:579–84.

    Article  PubMed  CAS  Google Scholar 

  31. Reichard P, Pihl M, Rosenqvist U, Sule J. Complications in IDDM are caused by elevated blood glucose levels:the Stockholm Diabetes Intervention Study (SDIS) at 10-years follow up. Diabetologia 1996;31:1483–8.

    Article  Google Scholar 

  32. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcome in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.

    Article  Google Scholar 

  33. Duckworth W, Abraira C, Moritz T, et al. Intensive glucose control and complications in American Veterans with type 2 diabetes. N Engl J Med. 2009;8:129–39.

    Article  Google Scholar 

  34. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain. Diabetes Care. 2008;31(Suppl 2):255–61.

    Google Scholar 

  35. Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the Nathan 1 trial. Diabetes Care. 2011;34:2054–60.

    Article  PubMed  CAS  Google Scholar 

  36. McIlduff CE, Rutkove SB. Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. Ther Clin Risk Manag. 2011;7:377–85.

    PubMed  CAS  Google Scholar 

  37. Ziegler D. Treatment of diabetic neuropathy: update 2006. Ann N Y Acad Sci. 2006;1084:250–68.

    Article  PubMed  CAS  Google Scholar 

  38. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;8:CD007076.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Interne Abteilung, Landeskrankenhaus Hochzirl, Hochzirl, Österreich

    Monika Lechleitner

  2. Internistisches Zentrum Baumgartner Höhe, Wien, Österreich

    Heidemarie Abrahamian

  3. Sonderkrankenanstalt Rehabilitationszentrum Alland, Alland, Österreich

    Mario Francesconi

Authors
  1. Monika Lechleitner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heidemarie Abrahamian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mario Francesconi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika Lechleitner.

Additional information

*Für den Ausschuss Leitlinien

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lechleitner, M., Abrahamian, H. & Francesconi, M. Die diabetische Neuropathie. Wien Klin Wochenschr 124 (Suppl 2), 33–38 (2012). https://doi.org/10.1007/s00508-012-0267-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-012-0267-1

Schlüsselwörter

Keywords

Search

Navigation